Switching to Potential Reduced Exposure Products in Adult Smokers (JUUL)
Addictive Behaviors | Mental Health & Behavioral Research | Tobacco Addiction
What is the purpose of this trial?
This study aims to assess the feasibility, acceptability, and the potential harm reduction of switching to potentially lower risk, non-combustible tobacco products in adult smokers. Part One of this study aims to assess the interest of current smokers in switching to an e-cigarette device (i.e. JUUL) compared to alternative non-combustible tobacco products (i.e. smokeless tobacco/snus) and/or medicinal nicotine via survey. Part Two will consist of a pilot study of 50 non-treatment seeking adult smokers with medical co-morbidities to investigate within-person changes in smoking behavior as a result of switching to different concentrations a nicotine salt electronic cigarette product (i.e. JUUL, 3% and 5% nicotine concentration). Additionally, by measuring bio-markers of tobacco exposure from baseline, this will allow the study to assess the potential for harm reduction in switching from cigarettes to an e-cigarette device.
- Ages21 years - 77 years
- Trial withNational Institute on Drug Abuse (NIDA)
- Start Date12/10/2018
- End Date09/30/2022
- Last Updated07/15/2021
- Study HIC#2000023826